Vasović Olga, Zamaklar Miroslava, Lalić Katarina, Milosević Dragoslav, Zikić Ljiljana, Popović Ljiljana
Institute for Gerontology, Home Treatment and Care, Belgrade.
Srp Arh Celok Lek. 2005 May-Jun;133(5-6):229-32. doi: 10.2298/sarh0506229v.
The prevalence of hypertension is two times higher in diabetics than in non-diabetics. In type 1 diabetes mellitus (T1DM), the incidence of hypertension is similar to the incidence of nephropathy. In obese patients with type 2 DM (T2DM) there can be associated complications of hyperinsulinaemia, dyslipidaemia, and hypertension, which can lead to coronary artery disease and stroke. These associated complications are the result of a genetic defect that produces insulin resistance--Syndrome X. Increased microalbuminuria correlates with increased levels of blood pressure (BP) and increased LDL cholesterol, and this is why microalbuminuria is associated with an increase in cardiovascular deaths in diabetics, even in the absence of renal failure.
The aim of this study was to research the influence of a patient's age, diabetes duration, and obesity on the frequency of hypertension and its association with microalbuminuria in T1 DM and T2DM.
168 hospitalised patients with DM (79 T1DM, 89 T2DM) were analysed. The main outcome measures were: 24-hour urinary albumin excretion rate by radioimmunoassay (MA = 30-300 mg/24h), arterial hypertension (systolic BP > or = 140 mm Hg and/or diastolic BP > or = 90 mm Hg), and body mass index (BMI).
Microalbuminuria was detected in 42% of patients with T1DM and 47% of patients with T2DM. 34% of T1DM patients and 78% of T2DM patients were hypertensive. Patients were divided into four groups, according to the presence of hypertension and microalbuminuria: Group I--patients with hypertension and MA, Group II--patients with hypertension but without MA, Group III--patients without hypertension and MA, Group IV--patients without hypertension but with MA. 44% of T1DM patients were without hypertension and microalbuminuria, while the most frequent T2DM patients were those with hypertension (37% with and 41% without microalbuminuria). A significant correlation between BMI and diastolic BP in both types of DM (p < 0.01 for T1DM, and p < 0.05 for T2DM) was discovered. T2DM hypertensive patients were obese and there was a significant correlation between a patient's systolic BP and his or her age (p < 0.05).
These results suggest that hypertension can be prevented in patients with T2DM with weight reduction. There was a significant association between hypertension and microalbuminuria, especially in T1DM patients. Tight control of blood pressure is essential for the reduction of microalbuminuria as well as further micro- and macro-vascular diabetic complications.
糖尿病患者中高血压的患病率是非糖尿病患者的两倍。在1型糖尿病(T1DM)中,高血压的发病率与肾病的发病率相似。在肥胖的2型糖尿病(T2DM)患者中,可能会出现高胰岛素血症、血脂异常和高血压等相关并发症,这些并发症可导致冠状动脉疾病和中风。这些相关并发症是由产生胰岛素抵抗的基因缺陷——X综合征引起的。微量白蛋白尿增加与血压(BP)升高和低密度脂蛋白胆固醇升高相关,这就是为什么即使在没有肾衰竭的情况下,微量白蛋白尿也与糖尿病患者心血管死亡增加有关。
本研究的目的是探讨患者年龄、糖尿病病程和肥胖对T1DM和T2DM患者高血压发生频率及其与微量白蛋白尿相关性的影响。
对168例住院糖尿病患者(79例T1DM,89例T2DM)进行分析。主要观察指标为:通过放射免疫测定法测定的24小时尿白蛋白排泄率(MA = 30 - 300 mg/24h)、动脉高血压(收缩压≥140 mmHg和/或舒张压≥90 mmHg)和体重指数(BMI)。
42%的T1DM患者和47%的T2DM患者检测到微量白蛋白尿。34%的T1DM患者和78%的T2DM患者患有高血压。根据是否存在高血压和微量白蛋白尿,将患者分为四组:第一组——患有高血压和MA的患者,第二组——患有高血压但无MA的患者,第三组——无高血压和MA的患者,第四组——无高血压但有MA的患者。44%的T1DM患者无高血压和微量白蛋白尿,而最常见的T2DM患者是患有高血压的患者(37%有微量白蛋白尿,41%无微量白蛋白尿)。在两种类型的糖尿病中,均发现BMI与舒张压之间存在显著相关性(T1DM中p < 0.01,T2DM中p < 0.05)。T2DM高血压患者肥胖,患者的收缩压与其年龄之间存在显著相关性(p < 0.05)。
这些结果表明,T2DM患者通过减轻体重可预防高血压。高血压与微量白蛋白尿之间存在显著关联,尤其是在T1DM患者中。严格控制血压对于减少微量白蛋白尿以及进一步预防糖尿病微血管和大血管并发症至关重要。